Definitive Contract 75A50124C00057
Award Date
9/30/24
Potential Completion Date
9/30/34
Potential Value
$174M
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rahway, NJ 07065, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $159,990,035.88 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Ridgeback Biotherapeutics LP, a for-profit woman-owned business, for the development and treatment of Ebola using the monoclonal antibody mAb114. The contract has an ultimate completion date of July 31, 2023. This sole-source contract was awarded on March 19, 2020 without a set-aside based on Ridgeback...
This is a $762,812,695.00 firm fixed price contract awarded by the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer of medical countermeasures. The contract is for the development of medical countermeasures that can be deployed in the event of a filovirus outbreak, which is a crucial component of the U.S. government's outbreak response plan. The...
This is a delivery order contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Department of Health and Human Services Office of the Assistant Secretary for Administration. The contract is for the provision of vaccines, with a potential value of $124,256.21. The contract is not set-aside and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). As a leading manufacturer of pharmaceuticals and vaccines, Merck has received numerous federal...
This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services (HHS) to Merck Sharp & Dohme LLC, doing business as Merck, a for-profit manufacturer of pharmaceuticals and vaccines. The $119,849.96 contract is for the delivery of Merck vaccines and is not associated with any set-aside program. Merck holds multiple federal contracts with agencies such as the Department of Veterans Affairs, Department of Defense, and Centers for Disease Control and Prevention...
This federal contract award, valued at $97,091.53, was issued by the Office of the Assistant Secretary for Administration (a civilian agency) to Merck Sharp & Dohme LLC, doing business as Merck, for the delivery of MERCK VACCINES FOR STOCK. The contract is a Firm Fixed Price Delivery Order without a set-aside designation. Merck is a major pharmaceutical manufacturer and supplier to the U.S. federal government, providing a wide range of vaccines, drugs, and medical countermeasures to...
This is a federal contract award by the Office of the Assistant Secretary for Administration, a civilian agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the U.S. government. The contract, valued at $366,413.50, is for the delivery of Merck vaccines for stock. The contract is a firm fixed-price delivery order with no set-aside designation. Merck holds several indefinite delivery vehicles (IDVs) with federal agencies, primarily...
This federal contract award is for the delivery of Merck vaccines to the U.S. government. The contract was awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a firm fixed price of $301,818.00 and a completion date of April 28, 2015. The award is not associated with a set-aside designation. It appears to be part of Merck's broader federal supply...
This is a delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The $95,935.20 firm fixed-price award is for the supply of vaccines to be delivered by October 28, 2017. It was placed under Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract does not have a set-aside designation. Merck holds several...
<p>This is a $81,976,383.00 definitive, cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Public Health Vaccines LLC, a self-certified small disadvantaged business, for the advanced research and development of an RVSV-MARV vaccine. The contract has an ultimate completion date of August 31, 2027 and was awarded on February 1, 2019. The contract does not have a set-aside designation.</p>
This federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, is for the provision of TRAVEL VACCINES. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, valued at a ceiling of $80,000.00. The award was made on February 22, 2025, with a final completion date of February 21, 2026. The contract is not designated as a set-aside. Merck is a major pharmaceutical manufacturer and supplier that has established itself as a critical...